University of Texas Texas AM Investment Management Co. Has $3.97 Million Stock Holdings in HCA Healthcare, Inc. $HCA

University of Texas Texas AM Investment Management Co. raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 227.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,506 shares of the company’s stock after buying an additional 5,909 shares during the quarter. HCA Healthcare comprises approximately 0.6% of University of Texas Texas AM Investment Management Co.’s investment portfolio, making the stock its 29th biggest holding. University of Texas Texas AM Investment Management Co.’s holdings in HCA Healthcare were worth $3,971,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Norges Bank bought a new position in shares of HCA Healthcare in the 4th quarter valued at about $1,262,513,000. Life Cycle Investment Partners Ltd acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $374,037,000. Viking Global Investors LP boosted its position in HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in HCA Healthcare by 4,545.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after purchasing an additional 649,058 shares during the period. Finally, Danske Bank A S bought a new position in HCA Healthcare in the third quarter valued at approximately $115,530,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HCA. UBS Group lifted their price target on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Weiss Ratings cut shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Oppenheimer cut their target price on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Royal Bank Of Canada decreased their target price on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Finally, KeyCorp lowered their target price on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Fifteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $506.14.

HCA Healthcare Stock Performance

HCA stock opened at $390.09 on Tuesday. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52. The company’s 50 day moving average price is $427.96 and its two-hundred day moving average price is $472.40. The company has a market capitalization of $86.54 billion, a PE ratio of 13.41, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same period in the prior year, the firm earned $6.45 earnings per share. The business’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is currently 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.